Osteopontin expression is an independent adverse prognostic factor in resectable gastrointestinal stromal tumor and its interaction with CD44 promotes tumor proliferation

Annals of Surgical Oncology

Volumn 17, Issue 11, 2010, Pages 3043-3052

  Hsu, Kai Hsi ^a,b   Tsai, Hung Wen ^a   Lin, Pin Wen ^a   Hsu, Yun Shang ^c   Shan, Yan Shen ^a   Lu, Pei Jung ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b Tainan Hospital   (Taiwan)

^c SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; OSTEOPONTIN;

ADULT; ARTICLE; BIOASSAY; CANCER CELL CULTURE; CELL CULTURE; CELL PROLIFERATION; DISEASE FREE SURVIVAL; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN INTERACTION; TUMOR GROWTH; WESTERN BLOTTING;

AGED; ANTIGENS, CD44; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; INTESTINAL NEOPLASMS; MALE; MIDDLE AGED; OSTEOPONTIN; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 78049477292     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1143-8     Document Type: Article

References (41)

1. S Hirota K Isozaki Y Moriyama, et al. 1998 Gain-of-function mutations of c-KIT in human gastrointestinal stromal tumors Science. 279 577 580 1:CAS:528:DyaK1cXotVyhsw%3D%3D 10.1126/science.279.5350.577 9438854 (Pubitemid 28067289)
2. CD Fletcher JJ Berman C Corless, et al. 2002 Diagnosis of gastrointestinal stromal tumors: a consensus approach Hum Pathol. 33 459 465 10.1053/hupa.2002.123545 12094370 (Pubitemid 34747864)
3. MC Heinrich CL Corless A Duensing, et al. 2003 PDGFRA activating mutations in gastrointestinal stromal tumors Science. 299 708 710 1:CAS:528:DC%2BD3sXntFWitQ%3D%3D 10.1126/science.1079666 12522257 (Pubitemid 36159485)
4. RP Dematteo KV Ballman CR Antonescu, et al. 2009 American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial Lancet. 373 1097 1104 1:CAS:528:DC%2BD1MXjslOltro%3D 10.1016/S0140-6736(09)60500-6 19303137
5. CL Corless JA Fletcher MC Heinrich 2004 Biology of gastrointestinal stromal tumors J Clin Oncol. 22 3813 3825 1:CAS:528:DC%2BD2cXhtVCitb%2FL 10.1200/JCO.2004.05.140 15365079 (Pubitemid 41095223)
6. CD Blanke 2009 Biomarkers in GIST: partly ready for prime-time use Clin Cancer Res. 15 5603 5605 1:CAS:528:DC%2BD1MXhtFars7%2FL 10.1158/1078-0432.CCR- 09-1563 19737947
7. C Keun Park EJ Lee M Kim HY Lim, et al. 2008 Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy Ann Surg. 247 1011 1018 10.1097/SLA.0b013e3181724f9d 18520229 (Pubitemid 351770422)
8. DR Senger DF Wirth RO Hynes 1979 Transformed mammalian cells secrete specific proteins and phosphoproteins Cell. 16 885 893 1:CAS:528: DyaE1MXktFyjsb0%3D 10.1016/0092-8674(79)90103-X 88265
9. DT Denhardt X Guo 1993 Osteopontin: a protein with diverse functions FASEB J. 7 1475 1482 1:CAS:528:DyaK2cXkvVaiug%3D%3D 8262332
10. DT Denhardt M Noda AW O'Regan D Pavlin JS Berman 2001 Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival J Clin Invest. 107 1055 1061 1:CAS:528: DC%2BD3MXjsVCjtL0%3D 10.1172/JCI12980 11342566
11. H Rangaswami A Bulbule GC Kundu 2006 Osteopontin: role in cell signaling and cancer progression Trends Cell Biol. 16 79 87 1:CAS:528:DC%2BD28XhsFOjsbc%3D 10.1016/j.tcb.2005.12.005 16406521 (Pubitemid 43247403)
12. D Coppola M Szabo D Boulware, et al. 2004 Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies Clin Cancer Res. 10 184 190 1:CAS:528:DC%2BD2cXkvF2msg%3D%3D 10.1158/1078-0432.CCR-1405-2 14734468 (Pubitemid 38114178)
13. SR Rittling AF Chambers 2004 Role of osteopontin in tumour progression Br J Cancer. 90 1877 1881 1:CAS:528:DC%2BD2cXjvVals7g%3D 10.1038/sj.bjc.6601839 15138464 (Pubitemid 38746324)
14. SV Ivanov AV Ivanova CM Goparaju Y Chen A Beck HI Pass 2009 Tumorigenic properties of alternative OPN isoforms in mesothelioma Biochem Biophys Res Commun. 382 514 518 1:CAS:528:DC%2BD1MXksVCntbc%3D 10.1016/j.bbrc.2009.03.042 19285954
15. V Takafuji M Forgues E Unsworth P Goldsmith XW Wang 2007 An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma Oncogene. 26 6361 6371 1:CAS:528:DC%2BD2sXhtV2is73K 10.1038/sj.onc.1210463 17452979 (Pubitemid 47494216)
16. J Zhao L Dong B Lu, et al. 2008 Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis Gastroenterology. 135 956 968 1:CAS:528:DC%2BD1cXhtFylsrnN 10.1053/j.gastro. 2008.05.025 18555021
17. GF Weber S Ashkar MJ Glimcher H Cantor 1996 Receptor-ligand interaction between CD44 and osteopontin (Eta-1) Science. 271 509 512 1:CAS:528: DyaK28XmvFyrtA%3D%3D 10.1126/science.271.5248.509 8560266
18. GF Weber S Ashkar H Cantor 1997 Interaction between CD44 and osteopontin as a potential basis for metastasis formation Proc Assoc Am Physicians. 109 1 9 1:CAS:528:DyaK2sXhtVemtLk%3D 9010911
19. GF Weber 2001 The metastasis gene osteopontin: a candidate target for cancer therapy Biochim Biophys Acta. 1552 61 85 1:CAS:528:DC%2BD38XhsFahs74%3D 11825687
20. NS Fedarko A Jain A Karadag MR Van Eman LW Fisher 2001 Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer Clin Cancer Res. 7 4060 4066 1:CAS:528:DC%2BD38XltFSitA%3D%3D 11751502
21. JH Kim SJ Skates T Uede, et al. 2002 Osteopontin as a potential diagnostic biomarker for ovarian cancer JAMA. 287 1671 1679 1:CAS:528: DC%2BD38XisFaru7k%3D 10.1001/jama.287.13.1671 11926891
22. JD Blasberg HI Pass CM Goparaju RM Flores S Lee JS Donington 2010 Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer J Clin Oncol. 28 936 941 1:CAS:528:DC%2BC3cXktF2lsbc%3D 10.1200/JCO.2009.25.5711 20085934
23. M Higashiyama T Ito E Tanaka Y Shimada 2007 Prognostic significance of osteopontin expression in human gastric carcinoma Ann Surg Oncol. 14 3419 3427 10.1245/s10434-007-9564-8 17896150 (Pubitemid 350160128)
24. N Dai Q Bao A Lu J Li 2007 Protein expression of osteopontin in tumor tissues is an independent prognostic indicator in gastric cancer Oncology. 72 89 96 1:CAS:528:DC%2BD2sXhtlyksLrK 10.1159/000111108 18004082 (Pubitemid 350249135)
25. F Rohde C Rimkus J Friederichs, et al. 2007 Expression of osteopontin, a target gene of de-regulated Wnt signaling, predicts survival in colon cancer Int J Cancer. 121 1717 1723 1:CAS:528:DC%2BD2sXhtVyktLfI 10.1002/ijc.22868 17565744 (Pubitemid 47417288)
26. CY Wu MS Wu EP Chiang, et al. 2007 Elevated plasma osteopontin associated with gastric cancer development, invasion and survival Gut. 56 782 789 1:CAS:528:DC%2BD2sXoslKisLc%3D 10.1136/gut.2006.109868 17148500 (Pubitemid 46854191)
27. PV Korita T Wakai Y Shirai, et al. 2008 Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma Hum Pathol. 39 1777 1783 1:CAS:528: DC%2BD1cXhtlyltb%2FF 10.1016/j.humpath.2008.05.006 18701136
28. R Zohar N Suzuki K Suzuki, et al. 2000 Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration J Cell Physiol. 184 118 130 1:CAS:528:DC%2BD3cXjvFynu7w%3D 10.1002/(SICI)1097- 4652(200007)184:1<118::AID-JCP13>3.0.CO;2-Y 10825241
29. YH Lin HF Yang-Yen 2001 The osteopontin-CD44 survival signal involves activation of the PI3 K/Akt signaling pathway J Biol Chem. 276 46024 46030 1:CAS:528:DC%2BD3MXptVymsb8%3D 10.1074/jbc.M105132200 11590166
30. H Teramoto MD Castellone RL Malek, et al. 2005 Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12 Oncogene. 24 489 501 1:CAS:528:DC%2BD2MXnsFShuw%3D%3D 10.1038/sj.onc.1208209 15516973 (Pubitemid 40188596)
31. B Desai MJ Rogers MA Chellaiah 2007 Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells Mol Cancer. 6 18 10.1186/1476-4598-6-18 17343740 (Pubitemid 46443394)
32. Hsu KH, Tsai HW, Lin PW, Hsu YS, Shan YS, Lu PJ. Clinical implication and mitotic effect of CD44 cleavage in relation to Osteopontin/CD44 interaction and dysregulated cell cycle protein in gastrointestinal stromal tumor. Ann Surg Oncol. doi: 10.1245/s10434-010-0927-1 [Online February 10, 2010].
33. O Söderberg KJ Leuchowius M Gullberg, et al. 2006 Direct observation of individual endogenous protein complexes in situ by proximity ligation Nat Methods. 3 995 1000 10.1038/nmeth947 17072308 (Pubitemid 44782698)
34. M Jarvius J Paulsson I Weibrecht, et al. 2007 In situ detection of phosphorylated platelet-derived growth factor receptor β using a generalized proximity ligation method Mol Cell Proteomics. 6 1500 1509 1:CAS:528:DC%2BD2sXhtVGqsrzO 10.1074/mcp.M700166-MCP200 17565975 (Pubitemid 47506163)
35. JS Gold M Gönen A Gutiérrez, et al. 2009 Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localized primary gastrointestinal stromal tumour: a retrospective analysis Lancet Oncol. 10 1045 1052 10.1016/S1470-2045(09)70242-6 19793678
36. H Joensuu 2008 Risk stratification of patients diagnosed with gastrointestinal stromal tumor Hum Pathol. 39 1411 1419 10.1016/j.humpath.2008. 06.025 18774375
37. LF Raheja DC Genetos CE Yellowley 2008 Hypoxic osteocytes recruit human MSCs through an OPN/CD44-mediated pathway Biochem Biophys Res Commun. 366 1061 1066 1:CAS:528:DC%2BD1cXislygsQ%3D%3D 10.1016/j.bbrc.2007.12.076 18155656
38. J Sun Y Xu Z Dai Y Sun 2009 Intermittent high glucose enhances proliferation of vascular smooth muscle cells by upregulating osteopontin Mol Cell Endocrinol. 313 64 69 1:CAS:528:DC%2BD1MXht1WqurvN 10.1016/j.mce.2009.08. 019 19723557
39. JL Lee MJ Wang PR Sudhir GD Chen CW Chi JY Chen 2007 Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44 V interaction enhances survival in gastrointestinal cancer cells Cancer Res. 67 2089 2097 1:CAS:528:DC%2BD2sXitlSjsr8%3D 10.1158/0008-5472.CAN-06-3625 17332338 (Pubitemid 46424227)
40. B Desai T Ma J Zhu MA Chellaiah 2009 Characterization of the expression of variant and standard CD44 in prostate cancer cells: identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface J Cell Biochem. 108 272 284 1:CAS:528:DC%2BD1MXhtVGju7rO 10.1002/jcb.22248 19582779
41. BW Robertson MA Chellaiah 2010 Osteopontin induces beta-catenin signaling through activation of Akt in prostate cancer cells Exp Cell Res. 316 1 11 1:CAS:528:DC%2BD1MXhsV2lurjP 10.1016/j.yexcr.2009.10.012 19850036